Fangzhou integrates DeepSeek-R1 for enhanced healthcare solutions

Published 18/02/2025, 14:44
© Reuters.

Investing.com -- Internet healthcare solutions leader, Fangzhou Inc. (06086.HK), announced on February 8th the successful integration and local deployment of the DeepSeek-R1 open-source large language model. This technological upgrade is set to enhance the company’s service capabilities and operational efficiency, promising more precise and personalized healthcare solutions for patients and healthcare providers.

Dr. Xie Fangmin, Founder, Chairman, and CEO of Fangzhou, expressed his enthusiasm for the integration of DeepSeek-R1, stating it as an important step in the company’s commitment to technological innovation. He anticipates the upgrade to bring significant improvements to the platform’s capabilities, enabling the delivery of better, more efficient healthcare services.

The local deployment of DeepSeek-R1 introduces advanced analytical and reasoning capabilities to Fangzhou’s platform. This allows for data-driven decision support and advanced functionality while ensuring privacy and data security. With the technical strengths of DeepSeek, Fangzhou can more effectively address the needs of a diverse user base of patients and healthcare providers.

For patients, the platform is expected to enhance health management by providing analysis of medical reports, test results, and other health data. This enables healthcare providers to offer medication guidance and post-diagnosis care plans based on these insights.

For healthcare providers, Fangzhou’s DeepSeek-R1 powered "AI Assistant" can simplify prescription reviews and patient management, enabling doctors to concentrate on more critical medical tasks. The model’s data-driven logic also includes science-based decision support, assisting in diagnosis and optimized treatment plans.

Looking into the future, Fangzhou has plans for developing several "AI Agent" applications in 2025. The aim is to utilize DeepSeek-R1’s powerful analytical reasoning capabilities to extract greater insights from medical data. By creating specialized "AI Agent" solutions, Fangzhou aims to push the Internet healthcare sector towards greater efficiency and precision.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.